$6.910
-0.156 (-2.26%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
ALGS Prediction & Forecast by Similar Chart Analysis
Alphio's ALGS stock price prediction model matches the current Aligos Therapeutics, Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $6.90 (-0.15%). The 1-week path is $6.97 (+0.83%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Aligos Therapeutics, Inc. Stock?
Aligos Therapeutics Inc is a good buy right now due to its recent positive developments and strong analyst support. The current price is $6.91, while analysts have set price targets as high as $60, suggesting significant upside potential. Additionally, the company has shown a remarkable 63.36% increase over the last 20 days, indicating positive momentum. However, investors should be cautious of the risk of a net loss of $1.5 million reported in Q2 2026, which, while improved from previous losses, still reflects ongoing challenges.
ALGS stock price ended at $6.91 on Friday, after losing -2.26%
Aligos Therapeutics, Inc. (ALGS) last closed at $6.91, losing -2.26%. These facts feed the 1-day and 1-week ALGS price prediction above.
Forecast Drivers
Aligos Therapeutics, Inc. (ALGS) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches ALGS, ranked by similarity.
Seasonality analysis for ALGS
Historically the probability of a positive August return for ALGS is 0.00%. December offers the highest probability of a positive month at 48.84%, while June is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.